Larry Richardson, a board-certified obesity medicine physician with 30 years of experience, we focus on empowering you to live a healthier, more vibrant life
The integration of home delivery services with chronic injectable therapies is transforming access and adherence, positioning direct-to-patient distribution as a critical enabler for scaling next-generation obesity treatments
Most patients prefer injecting in the evening because any nausea or GI effects tend to peak four to eight hours post-injection, meaning they occur during sleep
In short term analyses (1/2 year) evaluating quality adjusted life years (QALYs) and incremental cost effectiveness ratios (ICERs), semaglutide was the most cost-effective compared to exenatide, dulaglutide, liraglutide or no treatment 82 (Fig
In clinical trials for semaglutide as Wegovy, 6.2% of people taking Wegovy compared to 2.5% on a placebo had significant hypoglycemia
Start Your Semaglutide Journey Today: Are you ready to take control of your health and weight